Cargando…

Evaluating strategies for reversing CRISPR-Cas9 gene drives

A gene drive biases inheritance of a gene so that it increases in frequency within a population even when the gene confers no fitness benefit. There has been renewed interest in environmental releases of engineered gene drives due to recent proof of principle experiments with the CRISPR-Cas9 system...

Descripción completa

Detalles Bibliográficos
Autores principales: Vella, Michael R., Gunning, Christian E., Lloyd, Alun L., Gould, Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591286/
https://www.ncbi.nlm.nih.gov/pubmed/28887462
http://dx.doi.org/10.1038/s41598-017-10633-2
_version_ 1783262681882427392
author Vella, Michael R.
Gunning, Christian E.
Lloyd, Alun L.
Gould, Fred
author_facet Vella, Michael R.
Gunning, Christian E.
Lloyd, Alun L.
Gould, Fred
author_sort Vella, Michael R.
collection PubMed
description A gene drive biases inheritance of a gene so that it increases in frequency within a population even when the gene confers no fitness benefit. There has been renewed interest in environmental releases of engineered gene drives due to recent proof of principle experiments with the CRISPR-Cas9 system as a drive mechanism. Release of modified organisms, however, is controversial, especially when the drive mechanism could theoretically alter all individuals of a species. Thus, it is desirable to have countermeasures to reverse a drive if a problem arises. Several genetic mechanisms for limiting or eliminating gene drives have been proposed and/or developed, including synthetic resistance, reversal drives, and immunizing reversal drives. While predictions about efficacy of these mechanisms have been optimistic, we lack detailed analyses of their expected dynamics. We develop a discrete time model for population genetics of a drive and proposed genetic countermeasures. Efficacy of drive reversal varies between countermeasures. For some parameter values, the model predicts unexpected behavior including polymorphic equilibria and oscillatory dynamics. The timing and number of released individuals containing a genetic countermeasure can substantially impact outcomes. The choice among countermeasures by researchers and regulators will depend on specific goals and population parameters of target populations.
format Online
Article
Text
id pubmed-5591286
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-55912862017-09-13 Evaluating strategies for reversing CRISPR-Cas9 gene drives Vella, Michael R. Gunning, Christian E. Lloyd, Alun L. Gould, Fred Sci Rep Article A gene drive biases inheritance of a gene so that it increases in frequency within a population even when the gene confers no fitness benefit. There has been renewed interest in environmental releases of engineered gene drives due to recent proof of principle experiments with the CRISPR-Cas9 system as a drive mechanism. Release of modified organisms, however, is controversial, especially when the drive mechanism could theoretically alter all individuals of a species. Thus, it is desirable to have countermeasures to reverse a drive if a problem arises. Several genetic mechanisms for limiting or eliminating gene drives have been proposed and/or developed, including synthetic resistance, reversal drives, and immunizing reversal drives. While predictions about efficacy of these mechanisms have been optimistic, we lack detailed analyses of their expected dynamics. We develop a discrete time model for population genetics of a drive and proposed genetic countermeasures. Efficacy of drive reversal varies between countermeasures. For some parameter values, the model predicts unexpected behavior including polymorphic equilibria and oscillatory dynamics. The timing and number of released individuals containing a genetic countermeasure can substantially impact outcomes. The choice among countermeasures by researchers and regulators will depend on specific goals and population parameters of target populations. Nature Publishing Group UK 2017-09-08 /pmc/articles/PMC5591286/ /pubmed/28887462 http://dx.doi.org/10.1038/s41598-017-10633-2 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Vella, Michael R.
Gunning, Christian E.
Lloyd, Alun L.
Gould, Fred
Evaluating strategies for reversing CRISPR-Cas9 gene drives
title Evaluating strategies for reversing CRISPR-Cas9 gene drives
title_full Evaluating strategies for reversing CRISPR-Cas9 gene drives
title_fullStr Evaluating strategies for reversing CRISPR-Cas9 gene drives
title_full_unstemmed Evaluating strategies for reversing CRISPR-Cas9 gene drives
title_short Evaluating strategies for reversing CRISPR-Cas9 gene drives
title_sort evaluating strategies for reversing crispr-cas9 gene drives
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591286/
https://www.ncbi.nlm.nih.gov/pubmed/28887462
http://dx.doi.org/10.1038/s41598-017-10633-2
work_keys_str_mv AT vellamichaelr evaluatingstrategiesforreversingcrisprcas9genedrives
AT gunningchristiane evaluatingstrategiesforreversingcrisprcas9genedrives
AT lloydalunl evaluatingstrategiesforreversingcrisprcas9genedrives
AT gouldfred evaluatingstrategiesforreversingcrisprcas9genedrives